{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:45:26Z","timestamp":1787748326232,"version":"build-2784847793"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T00:00:00Z","timestamp":1702080000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005198","name":"Chinese Foundation for Hepatitis Prevention and Control","doi-asserted-by":"publisher","award":["TQGB20210068"],"award-info":[{"award-number":["TQGB20210068"]}],"id":[{"id":"10.13039\/501100005198","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81500451"],"award-info":[{"award-number":["81500451"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2019J10549"],"award-info":[{"award-number":["2019J10549"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jlr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jlr.2023.100483","type":"journal-article","created":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T05:32:47Z","timestamp":1702531967000},"page":"100483","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Effects of apolipoprotein H downregulation on lipid metabolism, fatty liver disease, and gut microbiota dysbiosis"],"prefix":"10.1016","volume":"65","author":[{"given":"Yaming","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiusong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binbin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Vineeth","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binbin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jlr.2023.100483_bib1","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.jlr.2023.100483_bib2","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cld.2023.01.001","article-title":"Nonalcoholic fatty liver disease: disease burden and disease Awareness","volume":"27","author":"Golabi","year":"2023","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.jlr.2023.100483_bib3","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cld.2023.01.007","article-title":"Economic burden and patient-reported outcomes of nonalcoholic fatty liver disease","volume":"27","author":"Stepanova","year":"2023","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.jlr.2023.100483_bib4","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jhep.2020.05.040","article-title":"Diverse effects of hepatic steatosis on fibrosis progression and functional cure in virologically quiescent chronic hepatitis B","volume":"73","author":"Mak","year":"2020","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.jlr.2023.100483_bib5","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1053\/j.gastro.2020.01.049","article-title":"Nonalcoholic fatty liver disease: modulating gut microbiota to improve severity?","volume":"158","author":"Aron-Wisnewsky","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jlr.2023.100483_bib6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ecl.2022.06.007","article-title":"Nonalcoholic fatty liver disease","volume":"52","author":"Isaacs","year":"2023","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.jlr.2023.100483_bib7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41575-020-00406-0","article-title":"Nonalcoholic fatty liver disease: another leap forward","volume":"18","author":"Abdelmalek","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jlr.2023.100483_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/j.2040-4603.2018.tb00008.x","article-title":"Triglyceride metabolism in the liver","volume":"8","author":"Alves-Bezerra","year":"2017","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.jlr.2023.100483_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101238","article-title":"Metabolic-associated fatty liver disease and lipoprotein metabolism","volume":"50","author":"Heeren","year":"2021","journal-title":"Mol. Metab."},{"key":"10.1016\/j.jlr.2023.100483_bib10","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ecl.2022.02.008","article-title":"Lipid and lipoprotein metabolism","volume":"51","author":"Feingold","year":"2022","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.jlr.2023.100483_bib11","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1182\/blood-2009-12-260976","article-title":"Beta2-glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome","volume":"116","author":"Agar","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jlr.2023.100483_bib12","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1538-7836.2011.04327.x","article-title":"Beta(2) -Glycoprotein I: evolution, structure and function","volume":"9","author":"de Groot","year":"2011","journal-title":"J.\u00a0Thromb. Haemost."},{"key":"10.1016\/j.jlr.2023.100483_bib13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0021-9150(94)90066-3","article-title":"Influence of apolipoprotein H polymorphism on levels of triglycerides","volume":"110","author":"Cassader","year":"1994","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jlr.2023.100483_bib14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s004390050465","article-title":"Molecular basis of the apolipoprotein H (beta 2-glycoprotein I) protein polymorphism","volume":"100","author":"Sanghera","year":"1997","journal-title":"Hum. Genet."},{"key":"10.1016\/j.jlr.2023.100483_bib15","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1046\/j.1432-1327.2000.01174.x","article-title":"A\u00a0hydrophobic sequence at position 313-316 (Leu-Ala-Phe-Trp) in the fifth domain of apolipoprotein H (beta2-glycoprotein I) is crucial for cardiolipin binding","volume":"267","author":"Mehdi","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.jlr.2023.100483_bib16","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1111\/j.1538-7836.2006.02036.x","article-title":"Interaction of beta2-glycoprotein I with members of the low density lipoprotein receptor family","volume":"4","author":"Pennings","year":"2006","journal-title":"J.\u00a0Thromb. Haemost."},{"key":"10.1016\/j.jlr.2023.100483_bib17","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1194\/jlr.M800155-JLR200","article-title":"Comprehensive evaluation of apolipoprotein H gene (APOH) variation identifies novel associations with measures of lipid metabolism in GENOA","volume":"49","author":"Leduc","year":"2008","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2023.100483_bib18","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/j.bbamem.2011.05.007","article-title":"Conformational changes of beta2-human glycoprotein I and lipid order in lipid-protein complexes","volume":"1808","author":"Paolorossi","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jlr.2023.100483_bib19","first-page":"7291","article-title":"Association of the Trp316Ser variant (rs1801690) near the apolipoprotein H (beta2-glycoprotein-I) gene and serum lipid levels","volume":"8","author":"Guo","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.jlr.2023.100483_bib20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12944-022-01699-7","article-title":"Alcohol-dependent downregulation of apolipoprotein H exacerbates fatty liver and gut microbiota dysbiosis in mice","volume":"21","author":"Liu","year":"2022","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.jlr.2023.100483_bib21","article-title":"Apolipoprotein H induces sex-specific steatohepatitis and gut dysbiosis during chronic hepatitis B infection","volume":"26","author":"Liu","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.jlr.2023.100483_bib22","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/nprot.2011.335","article-title":"Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry","volume":"6","author":"Dunn","year":"2011","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jlr.2023.100483_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2020.105906","article-title":"Apolipoprotein H drives hepatitis B surface antigen retention and endoplasmic reticulum stress during hepatitis B virus infection","volume":"131","author":"Liu","year":"2021","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jlr.2023.100483_bib24","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3390\/cells7120230","article-title":"Decreasing phosphatidylcholine on the surface of the lipid Droplet correlates with altered protein binding and steatosis","volume":"7","author":"Listenberger","year":"2018","journal-title":"Cells"},{"key":"10.1016\/j.jlr.2023.100483_bib25","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.3390\/biom10111497","article-title":"Sphingomyelinases and liver diseases","volume":"10","author":"Insausti-Urkia","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.jlr.2023.100483_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/srep43290","article-title":"Hyodeoxycholic acid derivatives as liver X receptor alpha and G-protein-coupled bile acid receptor agonists","volume":"7","author":"De Marino","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jlr.2023.100483_bib27","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/17474124.2019.1569513","article-title":"Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease","volume":"13","author":"Suk","year":"2019","journal-title":"Expert Rev. Gastroenterol. Hepatol."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227523001566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227523001566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T23:05:06Z","timestamp":1756767906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227523001566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0022227523001566"],"URL":"https:\/\/doi.org\/10.1016\/j.jlr.2023.100483","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of apolipoprotein H downregulation on lipid metabolism, fatty liver disease, and gut microbiota dysbiosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jlr.2023.100483","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"100483"}}